SensTrain is a healthcare startup founded in 2016 and headquartered in Stockton On Tees, UK. The company's slogan "A nonintrusive medical device for sensory neuromodulation, enabling effective at-home treatment of phantom limb pain with remote healthcare support," captures its core mission. SensTrain offers a nonintrusive medical device that addresses phantom limb pain through sensory neuromodulation, utilizing advanced Sensory Discrimination Training (SDT) with innovative patented technology. This enables individuals suffering from phantom limb pain to effectively manage their condition at home, supported by remote healthcare professionals. By providing at-home treatment and remote support, SensTrain's approach alleviates time pressures for both patients and medical staff. Although details about their last investment and investors are currently unavailable, SensTrain's innovative approach to addressing a niche medical issue positions them as a promising player in the healthcare sector.
There is no investment information
No recent news or press coverage available for 2PD Ltd.